Journal
HUMAN & EXPERIMENTAL TOXICOLOGY
Volume 34, Issue 5, Pages 557-560Publisher
SAGE PUBLICATIONS LTD
DOI: 10.1177/0960327114550886
Keywords
Case report; synthetic cannabinoids; seizure; psychoactive drugs
Categories
Funding
- University of Otago's Dean's Bequest Fund
Ask authors/readers for more resources
Synthetic cannabinoid use has become widespread, leading to increased burdens on health care providers. Symptoms range from agitation and psychosis to seizures and acute kidney injury. We report a case where a patient was assessed and treated twice within 12 h for seizures following synthetic cannabinoid intoxication. Blood sample determinations showed low concentrations of analogues not previously reported, some of which are legal. Clinicians should be aware that synthetic cannabinoids may cause an array of severe health consequences. Given the ever evolving structure of available analogues, clinicians must also be prepared for other unexpected adverse effects.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available